Anti-JC-virus antibody prevalence in a German MS cohort

Mult Scler. 2012 Jul;18(7):1054-5. doi: 10.1177/1352458511429955.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Viral / analysis*
  • Child
  • Cohort Studies
  • Female
  • Germany
  • Humans
  • JC Virus / immunology
  • Leukoencephalopathy, Progressive Multifocal / virology*
  • Male
  • Middle Aged
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / virology*
  • Natalizumab
  • Polyomavirus Infections / complications
  • Polyomavirus Infections / epidemiology*
  • Prevalence
  • Risk Factors

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Viral
  • Natalizumab